Long COVID Trial, Recruiting (NCT07110714)

Long COVID Trial, Recruiting NCT07110714 Sponsor: Eggensberger OHG Condition: Long COVID

Printed from Voxsanity (voxsanity.com.au) — NCT07110714 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Long Covid

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Post-COVID Syndrome (also known as Long COVID, ICD-10 code U08.9)
You are able to carry out most daily activities independently, such as eating, bathing, and moving around (measured by a score called the Barthel Index being above 80)
You own a smartphone that can be used to fill in digital questionnaires and run an app that measures heart rate
You are willing and able to give written agreement to take part in the trial

Who may not be able to join:

You have certain serious heart or blood vessel conditions, such as severe heart failure, unstable chest pain, or a recent heart attack
You have serious vein problems, such as a recent blood clot in a leg vein (deep vein thrombosis)
You have a serious neurological condition, such as epilepsy that is not well controlled
You already regularly practice Kneipp therapy (a type of water-based wellness treatment involving techniques like cold water applications)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rembert Koczulla, MD, Schön Klinik Berchtesgadener Land

Phone: +4983629103300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07110714

Sponsor: Eggensberger OHG

Phase: Not Applicable

Status: Recruiting

Condition: Long COVID

Trial contact: +4983629103300

More information: https://clinicaltrials.gov/study/NCT07110714

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Post-COVID Syndrome (also known as Long COVID, ICD-10 code U08.9)
You are able to carry out most daily activities independently, such as eating, bathing, and moving around (measured by a score called the Barthel Index being above 80)
You own a smartphone that can be used to fill in digital questionnaires and run an app that measures heart rate
You are willing and able to give written agreement to take part in the trial

Who may not be able to join:

You have certain serious heart or blood vessel conditions, such as severe heart failure, unstable chest pain, or a recent heart attack
You have serious vein problems, such as a recent blood clot in a leg vein (deep vein thrombosis)
You have a serious neurological condition, such as epilepsy that is not well controlled
You already regularly practice Kneipp therapy (a type of water-based wellness treatment involving techniques like cold water applications)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Eggensberger OHG

Registry

ClinicalTrials.gov

Start date

1 December 2025

Est. completion

31 January 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Health-related quality of life by Short Form-12 Health Survey (SF-12)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov